Peritoneal transport testing
- PMID: 20540028
Peritoneal transport testing
Abstract
Different tests can be used to provide valuable information about the function of the peritoneal membrane. The data obtained can be useful for tailoring dialysis adequacy, for the analysis of clinical problems such as ultrafiltration failure or to predict the development of more severe peritoneal membrane derangement. The most widely used peritoneal function test is the peritoneal equilibration test (PET), developed and described by Twardowski in 1987. PET is performed using a 2.27% glucose solution, and it lasts 4 hours. It measures peritoneal solute transport and ultrafiltration (UF), and it gives the possibility to categorize patients (high, high-average, low-average and low transporters). However, a PET with 3.86% glucose provides better information on UF, on the phenomenon of sodium sieving and an assessment of free water transport. Two recently developed tests (Mini-PET, Double Mini-PET) are promising tools to assess free water transport and the osmotic conductance to glucose. It is possible to integrate the 3.86%-PET with the new tests to obtain a complete PET: the Uni-PET (all these tests in 1 PET). The new insights into peritoneal function need a new standardization of the PET. It would be worth having a machine (PET machine) which performs the PET automatically to avoid possible mistakes during the performance of the manual PET and to allow an universal standardization of the test.
Similar articles
-
[Peritoneal equilibration test: actuality and future perspectives].G Ital Nefrol. 2007 Nov-Dec;24(6):510-25. G Ital Nefrol. 2007. PMID: 18278755 Review. Italian.
-
Estimates of peritoneal membrane function--new insights.Nephrol Dial Transplant. 2006 Jul;21 Suppl 2:ii16-9. doi: 10.1093/ndt/gfl186. Nephrol Dial Transplant. 2006. PMID: 16825253 Review.
-
Categorization of sodium sieving by 2.27% and 3.86% peritoneal equilibration tests--a comparative analysis in the clinical setting.Nephrol Dial Transplant. 2009 Nov;24(11):3513-20. doi: 10.1093/ndt/gfp319. Epub 2009 Jul 1. Nephrol Dial Transplant. 2009. PMID: 19570887 Clinical Trial.
-
[Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].Pol Merkur Lekarski. 2004 Aug;17(98):110-3. Pol Merkur Lekarski. 2004. PMID: 15603317 Polish.
-
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.J Nephrol. 2005 Jan-Feb;18(1):67-71. J Nephrol. 2005. PMID: 15772925 Clinical Trial.
Cited by
-
Comparison of three PET methods to assess peritoneal membrane transport.Braz J Med Biol Res. 2019;52(8):e8596. doi: 10.1590/1414-431X20198596. Epub 2019 Aug 5. Braz J Med Biol Res. 2019. PMID: 31389491 Free PMC article.
-
Potential of Autologous Adipose-Derived Mesenchymal Stem Cells in Peritoneal Fibrosis: A Pilot Study.Arch Iran Med. 2023 Feb 1;26(2):100-109. doi: 10.34172/aim.2023.16. Arch Iran Med. 2023. PMID: 37543930 Free PMC article.
-
Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.PLoS One. 2014 Nov 10;9(11):e112050. doi: 10.1371/journal.pone.0112050. eCollection 2014. PLoS One. 2014. PMID: 25384022 Free PMC article.
-
The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.J Nephrol. 2018 Feb;31(1):137-145. doi: 10.1007/s40620-016-0371-9. Epub 2016 Dec 24. J Nephrol. 2018. PMID: 28012100
-
Prediction of Mortality in Patients on Peritoneal Dialysis Based on the Fibrinogen Mannosylation.Cells. 2023 Jan 17;12(3):351. doi: 10.3390/cells12030351. Cells. 2023. PMID: 36766693 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources